Acadian Asset Management
FPRX

Acadian Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Acadian Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-358,021
Closed -$6.09M – 2445
2020
Q4 		$6.09M Sell
358,021
-282,539
-44% -$3.54M 0.02% 452
2020
Q3 		$3.01M Buy
640,560
+108,952
+20% +$553K 0.01% 555
2020
Q2 		$3.24M Buy
531,608
+105,746
+25% +$436K 0.01% 591
2020
Q1 		$967K Buy
425,862
+175,399
+70% +$744K 0.01% 801
2019
Q4 		$1.15M Buy
250,463
+94,242
+60% +$373K 0.01% 843
2019
Q3 		$606K Buy
156,221
+12,713
+9% +$69.8K ﹤0.01% 1031
2019
Q2 		$866K Buy
143,508
+57,078
+66% +$546K ﹤0.01% 841
2019
Q1 		$1.16M Buy
+86,430
New +$986K 0.01% 840
2017
Q2 		– Sell
-249,909
Closed -$9.04M – 1675
2017
Q1 		$9.04M Sell
249,909
-792,480
-76% -$34.9M 0.04% 306
2016
Q4 		$52.2M Sell
1,042,389
-68,943
-6% -$3.62M 0.25% 97
2016
Q3 		$58.3M Buy
1,111,332
+16,964
+2% +$810K 0.29% 99
2016
Q2 		$45.3M Buy
1,094,368
+578,411
+112% +$25.2M 0.23% 120
2016
Q1 		$21M Buy
+515,957
New +$17.7M 0.11% 194
2015
Q2 		– Sell
-832
Closed -$19K – 1556
2015
Q1 		$19K Buy
+832
New +$21K ﹤0.01% 1126

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Acadian Asset Management's FPRX Position: Q1 2021 in Review

Acadian Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 358,021 shares — an estimated $6.09M sold.

Acadian Asset Management first reported a position in FPRX in Q1 2015 and held it in 14 quarters. The position peaked at $58.3M in Q3 2016. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

  • Acadian Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Acadian Asset Management sold 358,021 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $6.09M.
  • Acadian Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2015 and held it in 14 quarters.
  • Acadian Asset Management's Five Prime Therapeutics, Inc. position peaked at $58.3M in Q3 2016.
  • 147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on Acadian Asset Management's 13F filing for Q1 2021, filed 11 May 2021.